TEREASA CONNOLLY: Open Payments
NPI 1326757667 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$653 in 29 payments from 10 companies in 2025. Trend: 2023 $606 · 2024 $656 · 2025 $653
Food & beverage: $653
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 7 | $145 |
| Boston Scientific Corporation | 5 | $106 |
| Novartis Pharmaceuticals Corporation | 4 | $83 |
| PFIZER INC. | 3 | $74 |
| Philips North America LLC | 2 | $56 |
| Kestra Medical Technology Services, Inc. | 2 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| Edwards Lifesciences Corporation | 1 | $38 |
| Amgen Inc. | 2 | $35 |
| ABIOMED | 1 | $26 |
Products named: VERQUVO, LEQVIO, ELIQUIS, ECC Solutions, Assure WCD, Kerendia, AVVIGO Guidance System, SAPIEN 3 Ultra RESILIA.
Industry payments across FL — which companies pay providers there.
